Chloride channel loss of function linked with white matter disease.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Multiple Sclerosis and Related Disorders

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.msard.2013.09.006PMID 25878000
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride.

  2013cited by this paper
• Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy

  2013cited by this paper
• Brain white matter oedema due to ClC-2 chloride channel deficiency: an observational analytical study.

  2013influential reference
• The Use of Aminopyridines in Neurological Disorders

  2012cited by this paper
• Ion channels on microglia: therapeutic targets for neuroprotection.

  2011influential reference
• Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis

  2011cited by this paper
• Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial.

  2010cited by this paper
• Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status

  2008cited by this paper
• Leukoencephalopathy upon Disruption of the Chloride Channel ClC-2

  2007cited by this paper
• Acid-sensing ion channel-1 contributes to axonal degeneration in autoimmune inflammation of the central nervous system

  2007influential reference

• No citing papers are available for this paper.